All oncology:

Lenon, Alexis NP

Rehmar, Victoria NP

Lew, Daryl NP

Tran, Hung C. MD

CHOC Oncology Patient Ball

Adolescent and Young Adult (AYA) Treatment Program at CHOC

Navalkele, Pournima D. MD

Sato, Mariko MD

Wu, Vivian NP

Morales, Sonia MD

Gomez, Esteban I. MD

Gooch, Megan MD

Side Effects of Chemotherapy and Radiation in Children

Nunez, Tanya NP

Yun, Christine S., NP

When a Child has a Low-Grade Glioma (Brain Tumor)

How immunotherapy works to treat your child’s cancer

Treating Your Child’s Cancer with Precision Medicine

Understanding and Treating Recurrent and Refractory Cancers

Johnson, Natalie M. NP

Chavan, Rishikesh S. MD

Miller, Tara L. NP

Klimpel, Lisa M. NP

ANBL1531, A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or Crizotinib Added to Intensive Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma (NBL) (IND# 134379)

An Open-label, Multicenter, Phase 2 Study Evaluating the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Subjects > 1 and < 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma